21 results
DEFM14A
RETA
Reata Pharmaceuticals Inc
22 Aug 23
Proxy related to merger
8:00am
with applicable laws and the possession by Reata of all permits necessary to conduct its business;
environmental matters, including compliance … with environmental laws by Reata and its subsidiaries;
Reata’s and its subsidiaries’ intellectual property rights;
the compliance by Reata and its
PREM14A
RETA
Reata Pharmaceuticals Inc
11 Aug 23
Preliminary proxy related to merger
4:38pm
and the possession by Reata of all permits necessary to conduct its business;
environmental matters, including compliance with environmental laws … Matters
A-27
Compliance with Law; Permits
A-27
Environmental Matters
A-28
Intellectual Property
A-28
Data Privacy and Security
A-30
Real Property
A-31
DEFA14A
RETA
Reata Pharmaceuticals Inc
31 Jul 23
Additional proxy soliciting materials
7:05am
with Law; Permits
TABLE OF CONTENTS
(Continued)
Page
Environmental Matters
Intellectual Property
Data Privacy and Security
Real Property
Material … of Justice or any successor thereto.
“EMA” shall mean the European Medicines Agency or any successor thereto.
“Environmental Law” shall mean all
8-K
EX-2.1
RETA
Reata Pharmaceuticals Inc
31 Jul 23
Voting and Support Agreement
7:01am
; Permits
TABLE OF CONTENTS
(Continued)
Page
Environmental Matters
Intellectual Property
Data Privacy and Security
Real Property
Material Contracts … of Justice or any successor thereto.
“EMA” shall mean the European Medicines Agency or any successor thereto.
“Environmental Law” shall mean all
8-K
EX-1.1
rnuga3
3 Dec 20
Entry into a Material Definitive Agreement
4:45pm
D
vdj tjtm2afi408j9rk
25 Jun 20
$50M in equity, sold $50M, 2 investors
5:07pm
8-K
EX-1.1
wenmgurpmnhd6a 72i6i
14 Nov 19
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
q8goz we86i6
16 Oct 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-1.1
zimg kg45xpmlt2hy
26 Jul 18
Entry into a Material Definitive Agreement
12:00am
10-K
zcfk6up c4z29m
3 Mar 17
Annual report
12:00am
D
lxwrqzt2oggq s3pv3
13 Jul 11
$300M in equity, sold $300M, 1 investor
12:00am
D
qv78e1n8
5 Oct 10
$79.33M in equity / options / securities to be acquired, sold $16.98M, 30 investors
12:00am